Thoretec Pipeline: HeartMate III Fully Magnetic LVAD Trial Set For 2012

Thoratec plans to start a clinical trial at the end of 2012 for its next-generation HeartMate III left ventricular assist device with a magnetically levitated rotor designed to help reduce the risk of pump-related clots, bleeding and strokes.